MXPA03005981A - Antagonistas de receptores de aminoacidos excitatorios. - Google Patents

Antagonistas de receptores de aminoacidos excitatorios.

Info

Publication number
MXPA03005981A
MXPA03005981A MXPA03005981A MXPA03005981A MXPA03005981A MX PA03005981 A MXPA03005981 A MX PA03005981A MX PA03005981 A MXPA03005981 A MX PA03005981A MX PA03005981 A MXPA03005981 A MX PA03005981A MX PA03005981 A MXPA03005981 A MX PA03005981A
Authority
MX
Mexico
Prior art keywords
amino acid
receptor antagonists
acid receptor
excitatory amino
excitatory
Prior art date
Application number
MXPA03005981A
Other languages
English (en)
Spanish (es)
Inventor
John Martinelli Michael
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MXPA03005981A publication Critical patent/MXPA03005981A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA03005981A 2001-01-05 2001-12-20 Antagonistas de receptores de aminoacidos excitatorios. MXPA03005981A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05
PCT/US2001/044715 WO2002053561A1 (en) 2001-01-05 2001-12-20 Excitatory amino acid receptor antagonists

Publications (1)

Publication Number Publication Date
MXPA03005981A true MXPA03005981A (es) 2003-09-10

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005981A MXPA03005981A (es) 2001-01-05 2001-12-20 Antagonistas de receptores de aminoacidos excitatorios.

Country Status (23)

Country Link
EP (1) EP1351955A1 (no)
JP (1) JP2004520335A (no)
KR (1) KR20030066797A (no)
CN (1) CN1484642A (no)
AR (1) AR035679A1 (no)
BR (1) BR0116672A (no)
CA (1) CA2431545A1 (no)
CZ (1) CZ20031856A3 (no)
DZ (1) DZ3460A1 (no)
EA (1) EA200300770A1 (no)
EC (1) ECSP034682A (no)
HR (1) HRP20030544A2 (no)
HU (1) HUP0302528A2 (no)
IL (1) IL156138A0 (no)
MX (1) MXPA03005981A (no)
NO (1) NO20032973L (no)
NZ (1) NZ525821A (no)
PE (1) PE20020792A1 (no)
PL (1) PL361934A1 (no)
SK (1) SK8242003A3 (no)
TW (1) TW591023B (no)
WO (1) WO2002053561A1 (no)
ZA (1) ZA200304311B (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
IL137684A0 (en) * 1998-02-06 2001-10-31 Smithkline Beechmam Plc Salts of paroxetine
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
DK1200073T3 (da) * 1999-07-06 2007-05-07 Lilly Co Eli Selektive iGluR5-receptorantagonister til behandling af migræne

Also Published As

Publication number Publication date
SK8242003A3 (en) 2004-01-08
PE20020792A1 (es) 2002-09-06
CN1484642A (zh) 2004-03-24
TW591023B (en) 2004-06-11
ZA200304311B (en) 2004-09-02
JP2004520335A (ja) 2004-07-08
IL156138A0 (en) 2003-12-23
ECSP034682A (es) 2003-08-29
NO20032973D0 (no) 2003-06-27
NO20032973L (no) 2003-06-27
NZ525821A (en) 2004-07-30
KR20030066797A (ko) 2003-08-09
AR035679A1 (es) 2004-06-23
PL361934A1 (en) 2004-10-18
HRP20030544A2 (en) 2004-08-31
BR0116672A (pt) 2003-09-23
HUP0302528A2 (hu) 2003-11-28
DZ3460A1 (fr) 2002-07-11
CA2431545A1 (en) 2002-07-11
EA200300770A1 (ru) 2003-10-30
CZ20031856A3 (cs) 2003-09-17
WO2002053561A1 (en) 2002-07-11
EP1351955A1 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
IL165841A0 (en) Mchir antagonists
AU2002341834A1 (en) Antagonists
EP1539766A4 (en) ANTAGONISTS OF PEPTIDE RECEPTORS RELATED TO THE GENE OF CALCITONIN
IL158013A0 (en) Disease-associated protein
MXPA03007869A (es) Inhibidores peptidicos de desformilasa.
AP2004003156A0 (en) Peptide deformylase inhibitors.
EP1359915A4 (en) UROTENSIN-II RECEPTOR ANTAGONISTS
EP1372688A4 (en) SOMATOSTATIN ANTAGONISTS
ZA956812B (en) Excitatory amino acid receptor antagonists.
MXPA03005982A (es) Antagonistas de receptores de aminoacidos excitadores.
MXPA03006408A (es) Antagonistas de receptores de histamina.
PL370367A1 (en) Ccr-3 receptor antagonists v
MXPA03005981A (es) Antagonistas de receptores de aminoacidos excitatorios.
MX258179B (es) Poliamidas.
AU2002227020A1 (en) Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
AU2002228736A1 (en) Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
MXPA03009930A (es) Antagonistas del receptor del factor liberador de corticotropina.
AU6455501A (en) Excitatory amino acid receptor modulators
GB0128161D0 (en) Receptor protein
AU2003219955A1 (en) Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
AU2001264554A1 (en) Excitatory amino acid receptor modulators
AU2003212418A8 (en) Peptide deformylase
GB0223877D0 (en) Receptor proteins
GB0220459D0 (en) Receptor proteins
AU2002235453A1 (en) Urotensin-ii receptor antagonists